Recruiting Heart Attack Studies in Miami Lakes
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is t...
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA)....
About Heart Attack Clinical Trials in Miami Lakes
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Miami Lakes, FL. These studies are seeking a combined 436 participants. Research is being sponsored by Eli Lilly and Company, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Miami Lakes — FAQ
Are there heart attack clinical trials in Miami Lakes?
Yes, there are 2 heart attack clinical trials currently recruiting in Miami Lakes, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami Lakes?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami Lakes research site will contact you about next steps.
Are clinical trials in Miami Lakes free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami Lakes studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Miami Lakes are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov